Advanced Biohealing (ABHB) Sees IPO Price of $14 - $16/Share

Advanced Biohealing, Inc. (Nasdaq: ABHB) filed an amended registration statement with the U.S. Securities and Exchange Commission today for an Initial Public Offering of its Ordinary Shares. Advanced Biohealing plans to sell 13,350,000 shares and sees an initial price of $14 - $16 per share. Advanced Biohealing has filed to list on the Nasdaq Global Market under the ticker "ABHB."

The offering is being made through BofA/Merrill Lynch, J.P. Morgan, Wells Fargo Securities, William Blair & Co., and Oppenheimer & Co.

Advanced Biohealing is a regenerative medicine company that develops, manufactures and commercializes cell-based therapies.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Lyntris files for IPO, plans to list on NYSE under "LYNX"
• Codexis prices public offering of 16.7M shares at $1.50 each
• Pelican Acquisition II prices $75M IPO on Nasdaq